454
Participants
Start Date
March 4, 2011
Primary Completion Date
February 24, 2012
Study Completion Date
February 24, 2012
Infanrix™-IPV+Hib
Intramuscular, 3 doses
Infanrix™ IPV
Intramuscular, 3 doses
Hiberix™
Intramuscular, 3 doses
Synflorix™
Intramuscular, 3 doses
Rotarix™
Oral, 2 doses
GSK Investigational Site, Daegu
GSK Investigational Site, Goyang
GSK Investigational Site, GyeongSangNam-do
GSK Investigational Site, Iksan
GSK Investigational Site, Jeonju Jeonbuk
GSK Investigational Site, Seongnam-si
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Suwon City, Gyeonggi-do
GSK Investigational Site, Uijeongbu, Gyeonggi-do
GSK Investigational Site, Wonju-si Kangwon-do
Lead Sponsor
GlaxoSmithKline
INDUSTRY